- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$0.39 BnMarket Estimate, 2026
$0.43 BnMarket Forecast, 2034
$0.95 BnCAGR, 2026–2034
10.45%Executive Summary: Latin America Blood Group Typing Market
- Market Scope: Comprehensive regional analysis of the Latin America blood group typing market, covering consumables (antisera reagents, red blood cell reagents, blood bank saline), instruments, and services utilized across hospitals, clinical laboratories, and blood banks for ABO, antigen, antibody screening, cross-matching, and HLA testing.
- Market Valuation: Valued at USD 0.39 billion in 2025, reaching USD 0.43 billion in 2026, and anticipated to expand to USD 0.95 billion by 2034, growing at a robust CAGR of 10.45% during the forecast period (2026 to 2034).
- Primary Growth Drivers: Rising demand for blood transfusions driven by traffic accidents, trauma cases, and surgical emergencies, increasing voluntary blood donation initiatives, and expanded prenatal testing applications for diagnosing Hemolytic Disease of mobility/newborns (HDN).
Key Market Segment Metrics
| Category | Leading Segment (Base Position) | Fastest-Growing / High-Growth Segment |
|---|---|---|
| By Product | Consumables & Antisera Reagents (dominated market share due to recurring, high-volume requirements in routine typing and cross-matching) | Automated Instruments & Molecular Assays (high-growth segments driven by labs upgrading to high-throughput, error-free automated platforms) |
| By Test Type | ABO & Cross-Matching (held the largest share as mandatory baseline procedures prior to every blood transfusion or surgical intervention) | Antibody Screening & HLA Testing (expanding rapidly due to rising complex immunological workups and specialized transfusion requirements) |
| By End User | Hospitals & Blood Banks (accounted for the dominant revenue share, serving as primary hubs for trauma care, surgeries, and blood collections) | Independent Clinical Laboratories (fast-growing segment outsourcing specialized diagnostic and prenatal blood typing panels) |
| By Country | Brazil & Mexico (market leaders in Latin America commanding the largest share due to extensive healthcare networks and trauma patient volumes) | Argentina & Chile (high-growth national markets benefiting from modernized blood banking infrastructure and regulatory standards) |
Major Market Players & Industry Landscape
Market Structure: Competitive regional landscape comprising global diagnostics leaders and specialized reagent manufacturers competing through automated analyzer placements, tender bids with healthcare ministries, and portfolio expansions in molecular typing.
Key Companies: Bio-Rad Laboratories, Inc., Grifols, S.A., Immucor Inc., Ortho Clinical Diagnostics, Inc., Quotient, Ltd., Novacyt Group, BAG Healthcare GmbH, Rapid Labs, Day Medical SA, DIAGAST, and AXO Science.
Download Free Sample Report
Latin America Blood Group Typing Market Size
The size of the Latin America blood group typing market was valued at USD 0.39 billion in 2025. This market is expected to grow at a CAGR of 10.45% from 2026 to 2034 and be worth USD 0.95 billion by 2034, up from USD 0.43 billion in 2026.
MARKET DRIVERS
Rising Blood Transfusions, Donations, and Prenatal Testing Fuel Demand
The increasing need for blood group typing in prenatal testing, the rising number of traffic accidents, crises, and trauma cases demanding blood transfusions, and the rising number of blood donations contribute to the expansion of the Latin America Blood group typing market. To safely donate blood or receive a blood transfusion, blood group typing is performed. It's also done to examine if a person's red blood cells have an Rh factor chemical on their surface. Road accidents result in significant blood loss, necessitating an emergency blood transfusion for those patients.
As a result, the market's growth is likely to be boosted throughout the forecast period. Some of the other factors projected to aid development include increased blood group typing in forensic sciences and an increase in demand for blood and related products. Due to an increase in the need for blood transfusions, the industry has a lot of potentials. Donor blood compatibility with recipient patients is critical for transfusion purposes. As a result, blood samples are cross-matched with each other before transfusion to ensure compatibility.
Before a blood transfusion, a blood bank would often run various tests, including screening for antibodies that might cause harm if transfused, screening for infectious agents, ABO group and Rh type, screening for blood-group antibodies, and serologic testing. The necessity of blood group typing is becoming increasingly important as the trend of blood donation as a social concern grows. Accidents are becoming more common, and the number of cancer patients is rising, driving the need for blood transfusions throughout the world. Blood group typing is a required test process before blood transfusions to determine blood compatibility between the donor and the receiver and the Rh factor. The market is expected to increase further as more of these tests diagnose Hemolytic Disease of the Newborn (HDN).
MARKET RESTRAINTS
Low Awareness, Infrastructure Gaps, and Risk of Infections Limit Growth
Blood bank regents’ sales are declining because of a lack of awareness and skilled professionals, which acts as a market restriction for blood group typing. Administrative and logistical issues, poor turnaround, high expense, the need for high-end equipment, and insufficient information systems for managing the results are all restricting factors.
Some challenges, such as a lack of blood service infrastructure, and the danger of infectious illnesses like hepatitis B and HIV, may hinder market expansion in the next few years.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| Segments Covered | By Product, Test Type, Technique, End User, and Country. |
| Various Analyses Covered | Global, Regional and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Countries Covered | UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe. |
| Market Leaders Profiled | Bio-Rad Laboratories, Inc., Grifols, S.A., Immucor Inc., Ortho Clinical Diagnostics, Inc., Quotient, Ltd., Novacyt Group, BAG Healthcare GmbH, Rapid Labs, Day medical SA, DIAGAST, and AXO Science. |
COUNTRY LEVEL ANALYSIS
Because of the lack of public knowledge regarding blood transfusion safety and the availability of large underpenetrated markets in each of these areas, Latin America is predicted to have a lower CAGR throughout the forecast period. In this area, the rising prevalence of infectious illness is a key issue, driving market expansion. On the other hand, the rising incidence of traffic accidents and trauma cases in this region is projected to increase these tests' adoption.
KEY MARKET PLAYERS
Bio-Rad Laboratories, Inc., Grifols, S.A., Immucor Inc., Ortho Clinical Diagnostics, Inc., Quotient, Ltd., Novacyt Group, BAG Healthcare GmbH, Rapid Labs, Day medical SA, DIAGAST, and AXO Science are some of the notable companies operating in the Latin America blood group typing market.
MARKET SEGMENTATION
This Latin America blood group typing market research report is segmented and sub-segmented into the following categories.
By Product
- Consumables
- Antisera Reagents
- Red Blood Cell Reagents
- Anti-Human Globulin Reagents
- Blood Bank Saline
- Instruments
- Services
By Test Type
- ABO
- Antigen
- Antibody Screening
- Cross Matching
- HLA
By Technique
- Assay
- PCR
- Microarray
- Massively Parallel Sequencing
By End User
- Hospitals
- Clinical Laboratories
- Blood Banks
By Country
- Brazil
- Mexico
- Argentina
- Chile
- Rest of Latin America